2nd Biennial Miami Precision Medicine 2024

The 2nd Biennial Miami Precision Medicine (MPM) 2024 conference will bring together diverse experts in the field to share their knowledge and approaches in moving the precision medicine field towards routine practice.  Precision Oncology- treating the right patient with the right treatment at the right time- has made substantial progress in developing novel and effective treatments that target specific molecular alterations in an increasing number of cancer types.  The course will examine the treatment landscape based on published and emerging data.

The conference will also illustrate the role of Artificial Intelligence (AI) in identifying patterns and innovative strategies for specific cancers and individual patient populations.  An interdisciplinary molecular tumor board case discussion will emphasize the role of germline and genomic alterations in selecting targeted treatments as well as present relevant precision medicine clinical trials.

The success of next-generation precision oncology depends not only on the discovery of new actionable disease characteristics and the integration of multi-omic data, but also on the dissemination of clinical information amongst healthcare providers and the ability of patients to access novel targeted anticancer therapies not only locally, but globally.

Patients and advocacy groups will have an opportunity to “sit at the table” and share their insight, learn about promising clinical trials and partner with physicians to develop new strategies tailored to their specific needs.

The conference’s goal is to promote and facilitate awareness, education and equity in precision medicine cancer care and ultimately to identify and overcome barriers to precision medicine.

1. Expedite adoption of germline and genomic testing in clinical practice
2. Interpret next generation sequencing (NGS) results
3. Interpret results of a liquid biopsy (ctDNA)
4. Explain the role of multi-omics in precision oncology
5. Summarize role of biomarkers in selection of targeted therapies and immunotherapies in different cancer types
6. Recognize the emerging role of Artificial Intelligence in precision medicine
7. Describe common molecular alterations and the role of molecular diagnostic tests in different cancer types
8. Summarize recent and emerging data from key studies in clinical and translational cancer research
9. Implement strategies designed to improve the quality of cancer care, address barriers to optimal care and enhance the patient experience
10. Identify the role of lifestyle intervention in the precision medicine care model
11. Identify the role of scentific advances in the field of cancer biology and tumor pathogenesis
12. Develop collaborations that will lead to improved clinical trial portfolio and clinical trial participation
13. Interact with patients and patient advocacy groups to promote access to molecularly-driven therapies and available clinical trials
14. Facilitate patient-oncology experts’ interaction and understanding of survivorship challenges in the era of precision medicine

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 11.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure and Conflict of Interest Mitigation:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and mitigated prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Cancellation Policy

Cancellations received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to University of Miami at [email protected].

University of Miami Healthcare System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Diplomat Beach Resort Hotel
3555 South Ocean Dr.
Hollywood, FL 33019
954-602-6000

Click Here for Hotel Reservations

* Group rate will be available until Monday, April 15th, 2024.

Parking:
Daily Valet Parking $52
Self Parking $25 ++ per day with unlimited in an out privileges

COURSE DIRECTOR
Carmen Calfa, MD
Associate Professor of Clinical Medicine, University of Miami Miller School of Medicine
Breast Medical Oncologist, Braman Family Breast Cancer Institute
Clinical Research Leader, Breast Site Disease Group
Medical Co-Director, Cancer Survivorship & Translational Behavioral Sciences
Associate Director of Community Outreach - Plantation
Sylvester Comprehensive Cancer Center 
University of Miami Miller School of Medicine

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Craig H. Moskowitz, MD
Professor of Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Co-Director, Faculty

Nothing to disclose

Estelamari Rodriguez, MD, MPH
Assistant Professor of Clinical Medicine
Sylvester Cancer Center
University of Miami, FL

Co-Director, Faculty

Advisor-Daiichi Sankyo, Inc.|Consulting Fee-Amgen, Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc. (Relationship has ended)|Advisor-Lilly (Any division) (Relationship has ended)|Advisor-Pfizer (Any division)|Advisor-Janssen (Any division)|Advisor-AstraZeneca (Any division)

Jonathan C. Trent, MD, PhD
Professor of Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Co-Director, Faculty

Nothing to disclose

Carmen Calfa, MD
Associate Professor of Clinical Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Course Director, Faculty

Nothing to disclose

Kathy Baker, JD
My Faulty Gene
Grand Saline, TX

Faculty

Amer Beitinjaneh, MD, MSc
MD
University of Miami
north Miami, FL

Faculty

Steven Bialick, DO
Voluntary Assistant Professor of Medicine
University of Miami Medical Group
Delray Beach , FL

Faculty

Nothing to disclose

Marijo Bilusic, MD, PhD
Professor of Clinical Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Grant or research support-Surface Oncology (Relationship has ended)|Grant or research support-Merck |Grant or research support-Lilly (Any division)|Grant or research support-Hookipa Biotech

Nicholas A. Borja, MD, FACMG
Assitant Professor of Clinical Genetics
University of Miami Miller School of Medicine
MIAMI, FL

Faculty

Nothing to disclose

R. Patricia Castillo, MD
Associate Professor of Clinical Radiology
University of Miami Miller School of Medicine
Miami, FL

Faculty

Nothing to disclose

Aman Chauhan, MD
Associate Professor of Medical Oncology
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Advisor-Ipsen Biopharmaceuticals, Inc.|Advisor-Crinetics|Advisor-Lexicon Pharmaceuticals, Inc.|Advisor-TerSera|Consulting Fee-Exelixis, Inc.|Consulting Fee-Curium|Consulting Fee-Seneca Therapeutics|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Clovis Oncology|Grant or research support-Seneca Therapeutics|Speakers Bureau-Crinetics

Tracy Crane, PhD, RDN
Associate Professor
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Gina D'Amato, Dr.
Dr.
sylvester
Miami, FL

Faculty

Macarena De La Fuente, MD
University of Miami
Miami, FL

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Servier|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AnHeart|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Rigel

Debbie Denardi, MBA
FORCE
Sunny Isles, FL

Faculty

Aditi Dhir, MD
Assistant Professor of Clinical Pediatrics
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Carmen Gomez-Fernandez, MD
Professor of Pathology and Otolaryngology
University of Miami Miller School of Medicine
Miami, FL

Faculty

Julie R Gralow, MD, FACP, FASCO
Executive Vice President and Chief Medical Officer
ASCO
Seattle, WA

Faculty

Nothing to disclose

Sakir Humayun H. Gultekin, MD, FCAP
University of Miami Miller SOM Department of Pathology
Miami, FL

Faculty

Peter Hosein, MD
Associate Professor of Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Antonio Iavarone, MD
Professor of Neurological Surgery
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Merce Jorda, MD
Professor and Chair of Pathology
University of Miami Miller School of Medicine
Miami, FL

Faculty

Nothing to disclose

Mariana Khawand-Azoulai, MD
Assistant Professor
University of Miami Medical Group
Miami, FL

Faculty

Felicia M. Knaul, PhD
Professor
University of Miami Miller School of Medicine
Miami, FL

Faculty

Elisa Krill-Jackson, MD
MD
University of Miami Miller School of Medicine
Aventura, FL

Faculty

Nothing to disclose

Chandrika Kurpad, MS, LCGC

Faculty

Anne Llewellyn, MS, BHSA, RN-BC, CCM, CRR
MS, BHSA, RN-BC, CCM, CRR
Nurse Advocates

Faculty

Jose Lutzky, MD
Professor of Clinical Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Advisor-Medison Pharma (Relationship has ended)|Advisor-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-agenus|Membership on Advisory Committees or Review Panels, Board Membership, etc.-celldex|Membership on Advisory Committees or Review Panels, Board Membership, etc.-T-Nanobio|Independent Contractor (included contracted research)-Dragonfly|Independent Contractor (included contracted research)-IDEAYA|Independent Contractor (included contracted research)-Takeda Pharmaceuticals (Any division)|Independent Contractor (included contracted research)-Vyriad|Independent Contractor (included contracted research)-iovance|Independent Contractor (included contracted research)-Agenus|Independent Contractor (included contracted research)-TriSalus|Independent Contractor (included contracted research)-Tango|Independent Contractor (included contracted research)-Replimune|Independent Contractor (included contracted research)-InstilBio (Relationship has ended)

Jessica MacIntyre, APRN, DNP, MBA, APRN, AOCNP
Executive Director, Clinical Operations
University of Miami/Sylvester
Miami, FL, FL

Faculty

Jaime R. Merchan, MD, MSc
Professor (Tenured)
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Royalties or Patent Beneficiary-UptoDate Inc|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division)|Grant or research support-Merck (Any division)|Grant or research support-Exelixis, Inc.|Grant or research support-Eisai, Inc. (Relationship has ended)|Grant or research support-Seattle Genetics, Inc.|Grant or research support-Arcus Pharmaceuticals, Imugene, Dynamicure, Trishula |Grant or research support-Sillajen Inc, Corvus Therapeutics, Replimune, Vyriad, BioNtech, Genentech, (Relationship has ended)

Patricia I. Moreno, PhD
Assistant Professor
University of Miami Miller School of Medicine
Miami, FL

Faculty

Nothing to disclose

William G. Nelson, MD, PhD
Marion I. Knott Director and Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD

Faculty

Ownership-Armis Biopharma|Ownership-Digital Harmonics|Royalties or Patent Beneficiary-Celgene Corporation|Paid consultant-Cephieid|Ownership-Brahm Astra Therapeutics|Royalties or Patent Beneficiary-Aduro Birotech

Stephen D. Nimer, MD
Professor of Medicine, Director
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Kristin Rojas, MD
MD
U Miami
Miami Beach, TX

Faculty

Andrew E. Rosenberg, MD
Professor of Clinical Pathology
University of Miami Miller School of Medicine
Miami, FL

Faculty

Nothing to disclose

Sara Rothschild

Faculty

Hope S. Rugo, MD
Professor of Medicine and Winterhof Family Professor of Breast Oncology
University of California San Francisco Comprehensive Cancer Center
San Francisco, CA

Faculty

Richard Schilsky, MD, FACP, FSCT, FASCO
Professor emeritus
University of Chicago
La Grange, IL

Faculty

Advisor-Brylogyx|Consulting Fee-Cellworks|Consulting Fee-EQRx (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Clarified Precision Oncology|Consulting Fee-Illumina (Relationship has ended)|Consulting Fee-Flatiron Health|Stocks or stock options, excluding diversified mutual funds-Leap Therapeutics|Advisor-Syapse|Advisor-Scandion Oncology|Stocks or stock options, excluding diversified mutual funds-ZephyrAI|Grant or research support-AstraZeneca (Any division)|Grant or research support-Bayer (Any division)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Genentech (Any division)|Grant or research support-Lilly (Any division)|Grant or research support-Merck (Any division)|Grant or research support-Pfizer (Any division)|Grant or research support-Seattle Genetics, Inc.|Grant or research support-Taiho Pharmaceutical

Pearl Seo, MD, MPH
Assistant Professor of Clinical Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Abdulrahman Sinno, MD
Associate Professor of Clinical Obstetrics Gynecology and Reproductive Sciences
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Daniel Sumarriva, MD
Senior Director, Molecular Science
Caris Life Sciences
Boca Raton, FL

Faculty

Debu Tripathy, MD
Professor
The University of Texas MD Anderson Cancer Center
Houston, TX

Faculty

Paid consultant-Pfizer (Any division)|Paid consultant-Novartis Corporation Pharmaceuticals|Paid consultant-AMBRX|Paid consultant-Menarini-Stemline|Paid consultant-Gilead Sciences, Inc.|Paid consultant-Sermonix|Paid consultant-Puma Biotechnology|Paid consultant-Roche (Any division)|Paid consultant-Beigene

Sangeetha Venugopal, MD, MS
Assistant Professor of Clinical Medicine
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Nothing to disclose

Erik A. Williams, MD
Assistant Professor
Sylvester Comprehensive Cancer Center
Miami, FL

Faculty

Employment-Roche (Any division)|Stocks or stock options, excluding diversified mutual funds-Roche (Any division)

To reserve your exhibit or sponsorship, click on:

Exhibit/Sponsorship Registration